Reuters logo
BRIEF-Medicenna presents updates on phase 2b clinical trial of MDNA55 at annual meeting of society of neuro-oncology
November 16, 2017 / 12:14 PM / in 25 days

BRIEF-Medicenna presents updates on phase 2b clinical trial of MDNA55 at annual meeting of society of neuro-oncology

Nov 16 (Reuters) - Medicenna Therapeutics Corp

* Medicenna presents updates on phase 2b clinical trial of MDNA55 at the annual meeting of the society of neuro-oncology Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below